Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,030.00    102.00 (2.60%)
Bid:
4,028.00
Ask:
4,032.00
Spread: 4.00 (0.099%)
Market Cap: £15.22b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
4th Mar 20143:53 pmRNSTreasury Stock
3rd Mar 20143:11 pmRNSTotal Voting Rights
11th Feb 20146:06 pmRNSDirector/PDMR Shareholding
11th Feb 20147:00 amRNSInterim Management Statement
5th Feb 20141:08 pmRNSDirector/PDMR Shareholding
3rd Feb 20144:31 pmRNSTotal Voting Rights
23rd Jan 20144:20 pmRNSHolding(s) in Company
14th Jan 20143:34 pmRNSTreasury Stock
7th Jan 201410:34 amRNSBlocklisting Interim Review
2nd Jan 201411:36 amRNSTotal Voting Rights
3rd Dec 20139:58 amRNSTreasury Stock
2nd Dec 20135:19 pmRNSTotal Voting Rights
2nd Dec 20135:04 pmRNSTreasury Stock
2nd Dec 20135:00 pmRNSDirector Declaration
29th Nov 20137:00 amRNSRevolving Credit Facility
27th Nov 201311:11 amRNSDirector/PDMR Shareholding
19th Nov 20131:32 pmRNSDoc re. Half Yearly Report
19th Nov 20137:00 amRNSHalf Yearly Report
8th Nov 201312:58 pmRNSNotice of Results
4th Nov 201311:14 amRNSTotal Voting Rights
3rd Oct 20131:59 pmRNSDirector/PDMR Shareholding
1st Oct 20132:39 pmRNSTotal Voting Rights
23rd Sep 201311:02 amRNSTreasury Stock
17th Sep 20133:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20139:46 amRNSTotal Voting Rights
22nd Aug 201311:52 amRNSTreasury Stock
16th Aug 20139:00 amRNSAnnual Information Update
7th Aug 20139:04 amRNSShare Transactions and Purchase of Own Shares
1st Aug 20133:12 pmRNSTotal Voting Rights
30th Jul 201312:08 pmRNSBlocklisting Interim Review
26th Jul 20133:22 pmRNSResult of AGM
25th Jul 20137:00 amRNSInterim Management Statement
5th Jul 20131:57 pmRNSDirector/PDMR Shareholding
1st Jul 201311:43 amRNSTotal Voting Rights
25th Jun 201312:23 pmRNSAnnual Financial Report
21st Jun 20131:26 pmRNSTreasury Stock
13th Jun 20137:17 amRNSFinal Results
3rd Jun 20139:39 amRNSTotal Voting Rights
30th May 201311:15 amRNSNotice of Results
20th May 20135:24 pmRNSTreasury Stock
1st May 201310:35 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSInvestor Site Visit and Trading Update
19th Apr 201311:27 amRNSTransaction in Own Shares
11th Apr 20139:00 amRNSDirectorate Change
8th Apr 201311:15 amRNSTreasury Stock
3rd Apr 201310:22 amRNSTotal Voting Rights
21st Mar 20137:00 amRNSTreasury Stock
20th Mar 20136:07 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSAcquisition
1st Mar 201311:33 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.